Business Wire
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Agios Pharmaceuticals, the first biopharmaceutical company focused on
discovering and developing novel cancer metabolism drugs, announced that
the leading scientific journal Science has published a review
article, “Understanding the Warburg Effect: The Metabolic
Requirements of Cell Proliferation,” authored by two of its
founders, Lewis C. Cantley, Ph.D., Director of the Cancer Center at Beth
Israel Deaconess Medical Center and Professor of Systems Biology and
Craig B. Thompson, M.D., Director, Abramson Cancer Center, University of
Pennsylvania, and one of its scientific advisors, Matthew Vander Heiden,
M.D., Ph.D., Instructor of Medicine, Dana Farber Cancer Institute and
Harvard Medical School... Read More
Science Review Abstract
Find a Doctor/Researcher
Make an Appointment
Refer a Patient
Make a Gift
Penn Cancer Network
